Program #812 • Available Wednesday, March 10, 2004
Certified for AMA PRA Category 1 Credits™ through Saturday, March 10, 2007

Treatment of Hyperlipidemia: Expanding the Horizon of Prevention

 

Program Description

Patients with elevations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides, and with reduced levels of high-density lipoprotein cholesterol (HDL-C), are at significant risk of developing coronary heart disease. Hypercholesterolemia is an important preventable risk factor for cardiovascular morbidity and mortality, as well as all-cause mortality. Several national medical organizations have developed guidelines for the assessment of patient risk and for treating lipid abnormalities. The physician must identify those patients with dyslipidemia and initiate early, aggressive treatment to prevent catastrophic disability and death. A variety of standard drugs, as well as new agents, may be used. This program focuses on applying the latest clinical and research recommendations in using these drugs, singly or in combination, as well as employing nonpharmacologic interventions in clinical practice.

(60 minutes)

Credit Information

Up to 2 AMA PRA Category 1 Credits™

This activity is designed for primary care physicians and other health care professionals with an interest in the management of patients with hyperlipidemia.

Learning Objectives

After taking part in this CME activity, participants should be able to:

CME Credit Designations

ACCME The Network for Continuing Medical Education (NCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA NCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP This activity has been reviewed and is acceptable for up to 2 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins Thursday, March 10, 2005. Term of approval is for one year from this date, with option for yearly renewal.

AOA This activity is eligible for up to 2 hours of credit in Category 2-A of the American Osteopathic Association.